CASE REPORT: METASTATIC MEDULLARY THYROID CANCER PRESENTING IN A YOUNG MALE
Main Article Content
Keywords
..
Abstract
Thyroid cancers stand out as the most prevalent among endocrine system malignancies, contributing to about 3.4% of all diagnosed cancers worldwide1. A distinct type within this category is medullary thyroid cancer, originating from parafollicular C cells traced back to neural crest origins. Upon microscopic examination of these cells, a unique amyloid backdrop becomes evident. These tumors have the intriguing ability to generate a range of substances, including calcitonin, carcinoembryonic antigen, serotonin, and chromogranin2. While around 75% of cases arise sporadically, the remaining 25% are tied to familial factors. Sporadic instances can emerge at any age, whereas the hereditary form tends to affect children and young adults, giving the disease a multifaceted demographic3.
References
2. Maxwell JE, Sherman SK, O'Dorisio TM, Howe JR. Medical management of metastatic medullary thyroid cancer. Cancer. 2014;120(21):3287-3301. doi:10.1002/cncr.28858
3. Elisei R, Schlumberger MJ, Müller SP, et al. Cabozantinib in progressive medullary thyroid cancer [published correction appears in J Clin Oncol. 2014 Jun 10;32(17):1864]. J Clin Oncol. 2013;31(29):3639-3646. doi:10.1200/JCO.2012.48.4659
4. Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016;388(10061):2783-2795. doi:10.1016/S0140-6736(16)30172-6
5. Ying AK, Huh W, Bottomley S, Evans DB, Waguespack SG. Thyroid cancer in young adults. Semin Oncol. 2009;36(3):258-274. doi:10.1053/j.seminoncol.2009.03.009
6. Machens A, Niccoli-Sire P, Hoegel J, et al. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med. 2003;349(16):1517-1525. doi:10.1056/NEJMoa012915
7. Leimbach RD, Hoang TD, Shakir MKM. Diagnostic Challenges of Medullary Thyroid Carcinoma. Oncology. 2021;99(7):422-432. doi:10.1159/000515373
8. Grubbs EG, Rich TA, Li G, et al. Recent advances in thyroid cancer. Curr Probl Surg. 2008;45(3):156-250. doi:10.1067/j.cpsurg.2007.12.010
9. Hadoux J, Pacini F, Tuttle RM, Schlumberger M. Management of advanced medullary thyroid cancer. Lancet Diabetes Endocrinol. 2016;4(1):64-71. doi:10.1016/S2213-8587(15)00337-X